We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Herceptin–Chemotherapy Drug Combo Keeps Women’s Breast Cancers at Bay

News   Jul 01, 2019 | Original story from ICR

 
Herceptin–Chemotherapy Drug Combo Keeps Women’s Breast Cancers at Bay
 
 
 

RELATED ARTICLES

Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

News

An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Queen Mary University of London.

READ MORE

Why Is Colon Cancer More Deadly in Patients Under 25 Years?

News

A new study examines reasons why colon cancer is more deadly in pediatric-age and young adult patients than adults age 25 and over. This finding suggests the need for more intensive surveillance and treatment in those who have symptoms.

READ MORE

Understanding Vaccine Hesitancy in China

News

Vaccine acceptance is a crucial public health issue, which has been exacerbated by the use of social media to spread content expressing vaccine hesitancy. Studies have shown that social media can provide new information regarding the dynamics of vaccine communication online, potentially affecting real-world vaccine behaviors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE